PT1551850E - 2 oxo-voruscharina e seus derivados - Google Patents

2 oxo-voruscharina e seus derivados

Info

Publication number
PT1551850E
PT1551850E PT03757941T PT03757941T PT1551850E PT 1551850 E PT1551850 E PT 1551850E PT 03757941 T PT03757941 T PT 03757941T PT 03757941 T PT03757941 T PT 03757941T PT 1551850 E PT1551850 E PT 1551850E
Authority
PT
Portugal
Prior art keywords
oxo
derivatives
disclosed
voruscharina
voruscharin
Prior art date
Application number
PT03757941T
Other languages
English (en)
Inventor
Quaquebeke Van Eric
Braekman Jean-Claude
Simon Gentiane
Guissou Pierre
Nacoulma Odile
Dewelle Janique
Darro Francis
Kiss Robert
Original Assignee
Unibioscreen Sa
Univ Bruxelles
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP20020447192 external-priority patent/EP1408043A1/en
Application filed by Unibioscreen Sa, Univ Bruxelles filed Critical Unibioscreen Sa
Publication of PT1551850E publication Critical patent/PT1551850E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/20Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PT03757941T 2002-10-09 2003-10-09 2 oxo-voruscharina e seus derivados PT1551850E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20020447192 EP1408043A1 (en) 2002-10-09 2002-10-09 2''oxo-voruscharin and analogues thereof
US42006702P 2002-10-21 2002-10-21

Publications (1)

Publication Number Publication Date
PT1551850E true PT1551850E (pt) 2006-10-31

Family

ID=32095057

Family Applications (1)

Application Number Title Priority Date Filing Date
PT03757941T PT1551850E (pt) 2002-10-09 2003-10-09 2 oxo-voruscharina e seus derivados

Country Status (13)

Country Link
US (1) US7320971B2 (pt)
EP (1) EP1551850B1 (pt)
JP (1) JP2006511483A (pt)
AT (1) ATE327240T1 (pt)
AU (1) AU2003273974B2 (pt)
CA (1) CA2501774C (pt)
DE (1) DE60305520T2 (pt)
DK (1) DK1551850T3 (pt)
ES (1) ES2265583T3 (pt)
HK (1) HK1082727A1 (pt)
MX (1) MXPA05003633A (pt)
PT (1) PT1551850E (pt)
WO (1) WO2004033465A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2009004890A (es) * 2006-11-09 2009-05-21 Unibioscreen Sa Direccionamiento de subunidades alpha-1 o alpha-3 de na+, k+-atpasa en el tratamiento de enfermedades proliferativas.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5645988A (en) * 1991-05-08 1997-07-08 The United States Of America As Represented By The Department Of Health And Human Services Methods of identifying drugs with selective effects against cancer cells
GB9710698D0 (en) * 1997-05-24 1997-07-16 Verkaik Margaretha S E Composition

Also Published As

Publication number Publication date
EP1551850B1 (en) 2006-05-24
EP1551850A1 (en) 2005-07-13
DE60305520T2 (de) 2007-05-16
WO2004033465A1 (en) 2004-04-22
MXPA05003633A (es) 2005-12-14
CA2501774C (en) 2011-12-06
CA2501774A1 (en) 2004-04-22
US7320971B2 (en) 2008-01-22
AU2003273974B2 (en) 2009-08-13
DK1551850T3 (da) 2006-09-25
JP2006511483A (ja) 2006-04-06
WO2004033465B1 (en) 2004-06-17
US20060166952A1 (en) 2006-07-27
ES2265583T3 (es) 2007-02-16
DE60305520D1 (de) 2006-06-29
AU2003273974A1 (en) 2004-05-04
ATE327240T1 (de) 2006-06-15
HK1082727A1 (en) 2006-06-16

Similar Documents

Publication Publication Date Title
DE60030741D1 (de) Chinazoline verbindungen als heilmittel
ATE368031T1 (de) Neue gamma secretase inhibitoren
ATE371656T1 (de) Heteroaryl-pyrimidinderivate als jak-inhibitoren
EA025871B9 (ru) Ингибиторы mek и способы их применения
NO20050525L (no) Benzimidazol-1-yl-tiofenforbindelser for behandling av cancer
NO20044475L (no) 2-(2,6-diklorfenyl)-diarulimidazoler
EA200900802A1 (ru) Способы и композиции для лечения амилоидных заболеваний
DE60312017D1 (de) Sulfonderivate zur hemmung von gamma-secretase
ATE396174T1 (de) Hydroxyalkylaminderivate als beta-secretase- inhibitoren und deren verwendung zur behandlung der alzheimerschen krankheit oder ähnlicher krankheiten
EA200600078A1 (ru) Способы и композиции для лечения амилоидных заболеваний
DE50310516D1 (de) Fredericamycin-derivate
DE60003863D1 (de) Dioxocyclopentylhydroxamsäure
BR0309343A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas
DE60324544D1 (de) Muskarin antagonisten
BR0309342A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
ATE238981T1 (de) Antitumorwirkstoffe
SE0003476D0 (sv) Compounds
EA200600992A1 (ru) Амиды тиазолидинона, амиды тиазолидинкарбоновой кислоты, способы их получения и их применение
BR0309996A (pt) Composto, composição farmacêutica, método de tratar ou melhorar doenças ou condições proliferativas, uso de um composto, e, método de tratar ou melhorar doenças inflamatórias
DE69917005D1 (de) Substituierte pyrrolobenzimidazolderivate zur entzündungshemmung
ATE419242T1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
BRPI0415355A (pt) triarilimidazóis
TW200730177A (en) 4 anilino-3-quinolinecarbonitriles for the treatment of cancer
PT1551850E (pt) 2 oxo-voruscharina e seus derivados